Genopathy
Gene-Disorder Association · Article
Gene
CHRNA1
Cholinergic Receptor Nicotinic Alpha 1 Subunit
Disorder
Myasthenic Syndrome, Congenital, 3a, Slow-Channel
First reported 1999
Key publication · disorder Congenital end-plate acetylcholinesterase deficiency caused by a nonsense mutation and an A-->G splice-donor-site mutation at position +3 of the collagenlike-tail-subunit gene (COLQ): how does G at position +3 result in aberrant splicing?American journal of human genetics · 1999
Manually curated
Association Review

In brief

The association between CHRNA1 (Cholinergic Receptor Nicotinic Alpha 1 Subunit) and Myasthenic Syndrome, Congenital, 3a, Slow-Channel is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 24
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CHRNA1

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Myasthenic Syndrome, Congenital, 3a, Slow-Channel

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

12 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Mechanism overlap

Shared mechanisms

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access